Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The HPV life cycle is differentiation-dependent, with cellular differentiation driving initiation of the late, productive stage of the viral life cycle. Here, we identify a role for the protein
NFX1
-123 in regulating keratinocyte differentiation and events of the late HPV life cycle.
NFX1
-123 itself increased with differentiation of epithelial cells. Greater
NFX1
-123 augmented differentiation marker expression and JNK phosphorylation in differentiating 16E6-expressing human foreskin keratinocytes (16E6 HFKs). This was associated with altered expression of
MKK4
and
MKK7
, upstream kinase regulators of JNK phosphorylation. Modulating levels of
NFX1
-123 in HPV16-positive W12E cells recapitulated the effects on differentiation markers, JNK phosphorylation, and
MKK4
/7 seen in 16E6 HFKs. Crucially, levels of
NFX1
-123 also correlated with expression of L1, the capsid protein of HPV. Altogether, these studies define a role for
NFX1
-123 in mediating epithelial differentiation through the JNK signaling pathway, potentially linking expression of cellular genes and HPV genes during differentiation.
...
PMID:HPV type 16 E6 and NFX1-123 augment JNK signaling to mediate keratinocyte differentiation and L1 expression. 3090 28